Clinical Trials Hit by Ransomware Attack on Health Tech Firm

Nicole Perlroth reports:

A Philadelphia company that sells software used in hundreds of clinical trials, including the crash effort to develop tests, treatments and a vaccine for the coronavirus, was hit by a ransomware attack that has slowed some of those trials over the past two weeks.

The attack on eResearchTechnology Inc., which has not previously been reported, began two weeks ago when employees discovered that they were locked out of their data by ransomware, an attack that holds victims’ data hostage until they pay to unlock it. ERT said clinical trial patients were never at risk, but customers said the attack forced trial researchers to track their patients with pen and paper.

Read more on the New York Times.

About the author: Dissent

Comments are closed.